We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-2.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$34.1B
AUM Growth
-$2.63B
(-7.2%)
Cap. Flow
-$362M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
13.14%
Holding
2,315
New
186
Increased
813
Reduced
981
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$283M |
| 2 |
Medtronic
MDT
|
+$96M |
| 3 |
Philip Morris
PM
|
+$80.4M |
| 4 |
United Parcel Service
UPS
|
+$75.5M |
| 5 |
Dominion Energy
D
|
+$74.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$178M |
| 2 |
General Mills
GIS
|
+$158M |
| 3 |
ExxonMobil
XOM
|
+$138M |
| 4 |
ServiceNow
NOW
|
+$96M |
| 5 |
Keysight
KEYS
|
+$72.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Financials | 15.14% |
| 3 | Technology | 13.55% |
| 4 | Consumer Discretionary | 8.1% |
| 5 | Consumer Staples | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Seacoast Banking Corp of Florida
SBCF
$3.27B
| $2.72M | 0.01% |
89,908
+44,910
| +100% | +$1.5M |
|
|
KDNY
827
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.72M | 0.01% |
+138,263
| New | +$2.77M |
|
828
Jabil
JBL
$31.1B
| $2.71M | 0.01% |
46,924
-72,466
| -61% | -$4.22M |
|
829
Kite Realty
KRG
$5.14B
| $2.7M | 0.01% |
156,921
-59,640
| -28% | -$1.14M |
|
|
EGRX
830
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2.69M | 0.01% |
101,634
-29,706
| -23% | -$1.09M |
|
831
Nektar Therapeutics
NKTR
$2.3B
| $2.68M | 0.01% |
55,804
+48,605
| +675% | +$2.89M |
|
|
AEL
832
DELISTED
American Equity Investment Life Holding Company
AEL
| $2.68M | 0.01% |
71,859
| – | – |
|
833
CACI
CACI
$13.9B
| $2.68M | 0.01% |
10,252
-782
| -7% | -$220K |
|
834
Advanced Energy
AEIS
$10.1B
| $2.67M | 0.01% |
34,564
+57
| +0.2% | +$4.89K |
|
|
AVTA
835
DELISTED
Avantax, Inc. Common Stock
AVTA
| $2.67M | 0.01% |
138,222
+24,120
| +21% | +$485K |
|
836
BWX Technologies
BWXT
$13.3B
| $2.67M | 0.01% |
52,959
+12,109
| +30% | +$654K |
|
837
Neogen
NEOG
$2.74B
| $2.66M | 0.01% |
190,709
+170,695
| +853% | +$3.44M |
|
838
East-West Bancorp
EWBC
$17.3B
| $2.65M | 0.01% |
39,394
-664
| -2% | -$47.2K |
|
839
Everest Group
EG
$14.5B
| $2.64M | 0.01% |
10,059
+105
| +1% | +$28.4K |
|
|
CASI
840
DELISTED
CASI Pharmaceuticals
CASI
| $2.64M | 0.01% |
1,015,000
| – | – |
|
841
Meritage Homes
MTH
$4.17B
| $2.64M | 0.01% |
75,130
+30,318
| +68% | +$1.23M |
|
842
Towne Bank
TOWN
$3.43B
| $2.62M | 0.01% |
97,826
+645
| +0.7% | +$18.5K |
|
843
United Therapeutics
UTHR
$21.4B
| $2.61M | 0.01% |
12,443
-74
| -0.6% | -$16.5K |
|
|
RVNC
844
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.6M | 0.01% |
96,146
-25,254
| -21% | -$512K |
|
|
SCWX
845
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $2.59M | 0.01% |
321,418
+20,439
| +7% | +$203K |
|
846
American Express
AXP
$211B
| $2.58M | 0.01% |
19,160
-121
| -0.6% | -$18.3K |
|
|
AVNS
847
DELISTED
Avanos Medical
AVNS
| $2.57M | 0.01% |
118,161
+23,028
| +24% | +$602K |
|
848
Axos Financial
AX
$5.25B
| $2.57M | 0.01% |
75,135
+8,089
| +12% | +$327K |
|
|
MAPS
849
DELISTED
WM TECHNOLOGY INC A
MAPS
| $2.57M | 0.01% |
1,594,703
-1,579,197
| -50% | -$4.48M |
|
850
Morgan Stanley
MS
$318B
| $2.56M | 0.01% |
32,362
-2,468
| -7% | -$208K |
|
Similar funds
Federated Hermes's Q3 2022 Portfolio in Review
As of Q3 2022, Federated Hermes held 2,315 positions worth $34.1B, down 7.2% from $36.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q3 2022 filing shows 186 new, 813 increased, 981 reduced and 182 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M. The largest sale was Cardinal Health, an estimated $178M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- Federated Hermes's largest Q3 2022 buy was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M.
- Federated Hermes added most to JPMorgan Chase in Q3 2022, an estimated $283M increase.
- Federated Hermes's biggest Q3 2022 reduction was Cardinal Health, cutting an estimated $178M.
- Federated Hermes fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $69.1M.
- Federated Hermes's ten largest holdings make up 13% of its $34.1B portfolio in Q3 2022.
- Federated Hermes opened 186 new positions and closed 182 in Q3 2022.
- Federated Hermes's portfolio value fell 7.2% quarter-over-quarter to $34.1B.
Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.